Carter's (CRI) Tops Q2 EPS by 26c ; Offers Guidance

Carter's (NYSE: CRI) reported Q2 EPS of $0.76, $0.26 better than the analyst estimate of $0.50. Revenue for the quarter came in at $564 million versus the consensus estimate of $568.81 million.

GUIDANCE:

Carter's sees FY2024 EPS of $4.60-$5.05, versus the consensus of $6.23. Carter's sees FY2024 revenue of $2.78-2.82 billion, versus the consensus of $2.92 billion.

Carter's sees Q3 2024 EPS of $1.10-$1.35, versus the consensus of $1.88. Carter's sees Q3 2024 revenue of $735-755 billion, versus the consensus of $805.9 billion.

For earnings history and earnings-related data on Carter's (CRI) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• AIG (AIG) call put ratio 4 calls to 1 put with a focus on June 26 weekly calls as share price up 3.9%
• Trump's CDC nominee to exit UnitedHealth, divest holdings